{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:15:13Z","timestamp":1772770513469,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aortic valve stenosis is one of the most common valvular abnormalities, which can manifest as angina, syncope, dyspnoea and sudden cardiac death. Transcatheter aortic valve implantation (TAVI) has been introduced as an alternative to surgical valve replacement in patients with severe aortic valve stenosis, resulting in less morbidity, shorter time to recovery and similar mortality rates. Progress in this field has reduced complication rates. However, the incidence of peri-procedural stroke remains relatively high (around 4%). To fully utilise the potential of TAVI, cerebral embolic protection devices (CEPD) have been developed and introduced. In this position paper, we aim to summarise the available data on several CEPD.<\/jats:p>","DOI":"10.1007\/s12471-020-01380-7","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T16:03:50Z","timestamp":1583769830000},"page":"249-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The rationale of using cerebral embolic protection devices during transcatheter aortic valve implantation"],"prefix":"10.1007","volume":"28","author":[{"given":"C.","family":"Simsek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. E.","family":"Sch\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"den Heijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Meuwissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"van den Branden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J. J.","family":"IJsselmuiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"issue":"12","key":"1380_CR1","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.recesp.2016.06.026","volume":"69","author":"C Moris","year":"2016","unstructured":"Moris\u00a0C, Pascual\u00a0I, Avanzas\u00a0P. Will TAVI be the standard of care in the treatment of aortic stenosis? Rev Esp Cardiol. 2016;69(12):1131\u20134.","journal-title":"Rev Esp Cardiol"},{"key":"1380_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/CIRCULATIONAHA.109.855866","volume":"121","author":"P Kahlert","year":"2010","unstructured":"Kahlert\u00a0P, Knipp\u00a0SC, Schlamann\u00a0M, Thielman\u00a0M, Al-Rashid\u00a0F, Weber\u00a0M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a\u00a0diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870\u20138.","journal-title":"Circulation"},{"issue":"13","key":"1380_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa022066","volume":"348","author":"SE Vermeer","year":"2003","unstructured":"Vermeer\u00a0SE, Prins\u00a0ND, den Heijer\u00a0T, Hofman\u00a0A, Koudstaal\u00a0PJ, Breteler\u00a0MM. Silent brain infarcts and the risk of dementia and cognitive decline. N\u00a0Engl J Med. 2003;348(13):1215\u201322.","journal-title":"N Engl J Med"},{"key":"1380_CR4","doi-asserted-by":"crossref","unstructured":"Seeger J, Gonska B, Otto M, Rottbauer W, Wohrle J. Cerebral embolic protection during transcatheter aortic valve replacement significantly reduces death and stroke compared with unprotected procedures. JACC CardiovasInterv. 2017;10(22):2297\u20132303.","DOI":"10.1016\/j.jcin.2017.06.037"},{"key":"1380_CR5","doi-asserted-by":"crossref","unstructured":"Schmidt T, Akdag O, Wohlmuth P, Thielsen T, Schewel D, Schewel J, et\u00a0al. Histological findings and predictors of cerebral debris from transcatheter aortic valve replacement: the ALSTER experience. J\u00a0Am Heart Assoc. 2016;5(11):pii:e004399","DOI":"10.1161\/JAHA.116.004399"},{"issue":"4","key":"1380_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jacc.2016.10.023","volume":"69","author":"SR Kapadia","year":"2017","unstructured":"Kapadia\u00a0SR, Kodali\u00a0S, Makkar\u00a0R, Mehran\u00a0R, Lazar\u00a0RM. Zivadinov R, et\u00a0al., SENTINEL TRIAL Investigators. Protection against cerebral embolism during transcatheter aortic valve replacement. J\u00a0Am Coll Cardiol. 2017;69(4):367\u201377.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1380_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4244\/EIJV12I4A84","volume":"12","author":"NM Van Mieghem","year":"2016","unstructured":"Van Mieghem\u00a0NM, van Gils\u00a0L, Ahmad\u00a0H, van Kesteren\u00a0F, van der Werf\u00a0HW, Brueren\u00a0G, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL\u2011C trial. EuroIntervention. 2016;12(4):499\u2013507.","journal-title":"EuroIntervention"},{"key":"1380_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/jama.2016.10302","volume":"316(6","author":"S Haussig","year":"2016","unstructured":"Haussig\u00a0S, Mangner\u00a0N, Dwyer\u00a0MG, Lehmkuhl\u00a0L, Lucke\u00a0C, Woitek\u00a0F, et al. Effect of a\u00a0cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA. 2016;316(6:592\u2013601.","journal-title":"JAMA"},{"issue":"1","key":"1380_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4244\/EIJY15M04_01","volume":"11","author":"A Baumbach","year":"2015","unstructured":"Baumbach\u00a0A, Mullen\u00a0M, Brickman\u00a0AM, Aggarwal\u00a0SK, Pietras\u00a0GG, Forrest\u00a0JK, et\u00a0al. Safety and performance of a\u00a0novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study. EuroIntervention. 2015;11(1):75\u201384.","journal-title":"EuroIntervention"},{"issue":"31","key":"1380_CR10","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/eurheartj\/ehv191","volume":"36","author":"AJ Lansky","year":"2015","unstructured":"Lansky\u00a0AJ, Schofer\u00a0J, Tchetche\u00a0D, Stella\u00a0P, Pietras\u00a0CG, Parise\u00a0H, et\u00a0al. A prospective randomized evaluation of the Triguard HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart\u00a0J. 2015;36(31):2070\u20138.","journal-title":"Eur Heart J"},{"issue":"7","key":"1380_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jcin.2015.03.014","volume":"8","author":"RP Gooley","year":"2015","unstructured":"Gooley\u00a0RP, Talman\u00a0AH, Cameron\u00a0JD, Lockwood\u00a0SM, Meredith\u00a0IT. Comparison of self-expanding and mechanically expanded transcatheter aortic valve prostheses. JACC Cardiovasc Interv. 2015;8(7):962\u201371.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01380-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12471-020-01380-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01380-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T01:18:35Z","timestamp":1615252715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12471-020-01380-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1380"],"URL":"https:\/\/doi.org\/10.1007\/s12471-020-01380-7","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"9 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.\u00a0Simsek, B.E.\u00a0Sch\u00f6lzel, P.\u00a0den Heijer, J.\u00a0Vos, M.\u00a0Meuwissen, B.\u00a0van den Branden and A.J.J.\u00a0IJsselmuiden declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}